High-risk Myelodysplastic Syndrome
📧 Sign up to get email alerts when something new happens for High-risk Myelodysplastic Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-10-10Clinical Trial Update: HDM201 in Combination With MBG453 or Venetoclax in Patients With Acute Myeloid Leukemia (AML) or High-risk Myelodysplastic Syndrome (MDS) [Phase 1]
A Phase 1 trial investigating HDM201 in combination with MBG453 or venetoclax in patients with acute myeloid leukemia or high-risk myelodysp…